Did not become law. It stopped in the Senate's Finance, Revenue and Bonding Committee on January 17, 2025. The 2025 session has ended.
2025 Regular Session
Senate Bill 736
AN ACT CONCERNING RESEARCH AND DEVELOPMENT TAX CREDITS FOR BIOTECHNOLOGY COMPANIES.
What it does
The synopsis the General Assembly published with the bill.
To increase, for biotechnology companies, the caps on research and development credit exchanges and utilization and establish a tax credit for research and development expenses of biotechnology pass-through entities.
Sponsors
Who carried the bill in each chamber, and who signed on. Each name leads to the member's page.
In the Senate
Sponsor
Chief co-sponsor
In the House of Representatives
Sponsor
Chief co-sponsor
Its course
January 17 to January 17, 2025, on one scale. In the top row each mark is a day something happened; taller marks are busier days.
Each committee stop sits inside its chamber.
Every action1 action on 1 day
In the SenateJan 17 to Jan 17 · stopped0 days
Finance, Revenue and Bonding CommitteeJan 17 to Jan 17 · stopped0 days
Text
Each version as the General Assembly printed it.
l9n doesn't hold this bill's text yet.
What happened
In l9n's words, one line for each step. Every action as the General Assembly published it is below.
In the Senate Jan 17
- Jan 17Introduced and sent to Finance, Revenue and Bonding Committee
All 1 actions, as published
- Jan 17REF. TO JOINT COMM. ONBoth houses